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Abstract  
BACKGROUND: Intestinal fatty acid binding proteins (I-FABPs) are mainly expressed in the 
intestinal villi, which are the initial site of destruction in viral gastroenteritis. 
AIM: This study was designed to assess serum I-FABPs as a predictor of gut wall integrity loss in 
viral gastroenteritis.  
PATIENTS AND METHODS: This case-control cross-sectional study was conducted on 93 cases 
of acute viral gastroenteritis. Twenty-eight healthy children matching in age were recruited as 
control group. Serum I-FABPs were measured using ELISA technique. Viral detection and typing 
were done by PCR for adenovirus, and by Reverse transcriptase PCR for rotavirus, astrovirus and 
norovirus. 
RESULTS: Serum I-FABPs level was significantly higher in the cases compared to the controls and 
was also higher in the 46 rotavirus gastroenteritis cases compared to other viral gastroenteritis 
cases. Serum I- FABPs level was significantly higher in severely dehydrated cases as compared to 
mildly dehydrated ones (P=0.037).  
CONCLUSION: Serum I-FABPs could be used as an early and sensitive predictor marker of gut 
wall integrity loss in children with viral gastroenteritis and its level can indicate case severity.   
 
 
 
 
 
 
 
Introduction 
 
Acute viral gastroenteritis (GE) is one of the 
commonest causes of morbidity and mortality in very 
young aged children [1-3]. This is definitely due to the 
dehydrating diarrhea and might be also due to 
secondary blood stream infection [4]. Four major viral 
pathogens associated with AGE are three RNA 
viruses (rotavirus, norovirus, and astrovirus) and one 
DNA virus (enteric adenovirus) [4-6]. Co-infections 
with these viruses have been frequently reported 
especially rotavirus and norovirus co-infections [7-9]. 
Rotavirus remains the most common cause of 
severe childhood diarrhea worldwide and of diarrheal 
mortality in developing countries [10]. The World 
Health Organization (WHO) estimates that 527,000 
children under the age of five years die of rotavirus 
disease each year [11]. Children in the poorest 
countries account for 82% of rotavirus deaths in 
children, fewer than five years of age [12, 13]. 
Loss of gut wall integrity, and intestinal 
ischemia are consequence of low flow states 
associated with viral gastroenteritis. Prolonged 
periods of intestinal ischemia reperfusion result in 
severe damage to the intestinal barrier, thereby 
allowing translocation of bacteria from the intestinal 
lumen to the systemic circulation [14]. As early 
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detection of intestinal ischemia reperfusion is 
essential to improve clinical outcome, Derikx et al., 
[15], and Grootjans et al., [16] have studied the 
diagnostic value of biomarkers to detect enterocyte 
membrane integrity loss, an early phenomenon during 
intestinal ischemia. 
Intestinal fatty-acid binding protein (I-FABP) is 
a newly sensitive plasma marker of for early 
enterocyte membrane integrity loss. Several studies 
have described the use of I-FABP for the early 
detection of intestinal injury due to decreased 
perfusion of the small bowel, inflammation, or 
intestinal ischemia [17, 18]. It is part of a family of nine 
different FABP types, each named after the tissue of 
its first detection. I-FABPs are small (15 kDa) low 
molecular weight cytosolic proteins specifically 
present in mature enterocytes at the tip of the villus of 
small intestine and constitute 2% of enterocyte 
proteins. They are released upon enterocyte 
membrane integrity loss into the circulation, which 
makes them useful as plasma markers for enterocyte 
damage [19]. Assessment of gut wall integrity in 
clinical practice is still a challenge, as it is difficult to 
evaluate the condition of the gut non-invasively with 
currently available diagnostic tools. Moreover, non-
invasive, rapid diagnostic means to assess intestinal 
condition are needed to evaluate the effects of 
treatment of intestinal disorders. Therefore, the aim of 
this current study is to assess serum intestinal fatty 
acid binding protein (I-FABP) as an early and 
sensitive predictor for the evaluation of gut wall 
integrity loss in GE particularly rotavirus 
gastroenteritis (RV-GE) in Egypt. 
 
 
Subjects and Methods 
 
Subjects  
This cross sectional case control study was 
conducted on 93 cases of acute gastroenteritis. They 
were 55 males and 38 females. Their ages ranged 
from newborn up to 5 years old. They belonged to 
different social classes and were taken from Cairo, 
Giza and Kalyoubia governorates in Egypt. Thirty-two 
of these cases were hospitalized while the other sixty-
one cases were not. Of these, eleven cases just 
entered the hospital to receive I.V. fluids and then 
were dismissed. The remaining 50 cases were taken 
from the outpatient clinics of the same hospitals.  
 
Inclusion Criteria  
1. Age range (newborn up to 5 years old). 
2. Boys and girls of the same social classes are 
included. 
Exclusion Criteria  
1. Infants receiving Rota virus vaccine. 
2. Children on corticosteroids or 
immunosuppressive drug therapy. 
3. Children complaining of systemic auto-
immune disease, immunodeficiency, chronic 
renal disease, or cancer. 
4. Previous blood or any blood products 
transfusion. 
5. History of chronic allergic diseases. 
The control group comprised 28 apparently 
healthy children who did not have diarrhea during the 
2 weeks period preceding enrollment in the study. 
They belonged to the same regions and were of the 
same age range. They were 13 males and 15 
females.  
Ethical approval was obtained from the 
Medical Ethical Committee of the National Research 
Centre. Written informed consent was obtained from 
the parents after explanation of the aim of the study 
and its possible benefits for identifying the cause of 
the acute viral gastroenteritis of their children. 
 
Methods 
All cases were subjected to full history taking, 
thorough clinical examination, and collection of clinical 
data. Clinical data included disease manifestations as 
fever, vomiting, abdominal pain or bloody diarrhea. 
Severity criteria like duration of the diarrhea, number 
of stool motions or bouts of vomiting, range of body 
temperature, and degree of dehydration were 
determined for all hospitalized children. 
Blood samples approximately 3 ml were taken 
from all cases and controls for measuring intestinal 
fatty acid binding protein (I-FABP). Serum was 
immediately separated from each blood sample and 
stored frozen at −20°C till the measurement of I-
FABP. Serum I-FABP levels were analyzed using the 
human I-FABP-specific enzyme-linked immunos-
orbent assay (ELISA) commercial test kit (EIAab®, 
China), according to the following steps. Firstly, 100 μl 
of standard, blank, and samples were added per well 
that wells were pre-coated with biotin-conjugated 
polyclonal antibody specific to human iFABP. Then, 
the plate covered with the plate sealer was incubated 
for 2 hours at 37°C. After incubation 100 μl of avidin 
conjugated was added to each well then plate covered 
and incubated for 1 hour at 37°C then each well 
aspirated and washed three times. After washing, 100 
μl of horseradish peroxidase (HRP) was added to 
each microplate well then the plate incubated for 1 
hour at 37°C. After incubation each well was aspirated 
and washed. This wash step was followed by addition 
of 90 μl TMB substrate solution to each well then the 
plate incubated for 30 minutes at 37°C and protected 
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from light. The enzyme-substrate reaction was 
terminated by the addition of 50 μl sulphuric acid 
solution and the color change was measured using 
microplate reader at a wavelength of 450 nm [20]. 
Stool analysis was done by using Polymerase 
Chain Reaction (PCR) and by Reverse transcriptase 
PCR (RT-PCR) for viral detection and typing. Stool 
samples were collected in dry sterile clean plastic 
cups. Collected samples were diluted and prepared 
for PCR, and RT-PCR for detection of viral 
gastroenteritis agents in the collected samples. Viral 
gastroenteritis was detected in all collected stool 
samples were subjected to extraction of both viral 
RNA and DNA in the samples using Axygen® Kit 
(Axygen biosciences, Cat. No AP-MN-BF-VNA-250) to 
facilitate the detection of both RNA gastroenteritis 
viruses (such as rotaviruses, noroviruses, and 
astroviruses) and DNA gastroenteritis viruses (such 
as adenoviruses).  
 Viral genomes were extracted from 10% 
diluted stool samples using Axygen® Kit (Axygen 
biosciences, Cat. No. AP-MN-BF-VNA-250) according 
to manufacturers instructions and prepared for 
detection of viral gastroenteritis by both RT-PCR and 
PCR using sets of oligonucleotide primers specific to 
each type of virus Universal viral gastroenteritis 
oligonucleotide primers sequences were obtained 
from Bioneer Company, as purified lyophilized 
primers. Universal primers for G typing rotaviruses 
were selected for amplification of segment 9 as 
previously described [21]. These primer pairs are semi 
nested primers designed to amplify the highly 
conserved region among all known rotaviruses strains 
and specific for gene segment 9, as. Universal 
primers for P typing rotaviruses were selected for 
amplification of VP7 gene segment [22]. For detection 
of astroviruses sets of primers were selected and 
used as described by [23], and noroviruses sets of 
primers were used [24]. For adenoviruses PCR the 
primer sets described by [25] and designed to amplify 
the highly conserved region of hexon gene which is 
very similar in many types of adenoviruses.  
 Reverse transcriptase-polymerase chain 
reaction (RT-PCR): 
 All collected stool samples were subjected to 
extraction of both viral RNA and DNA in the samples 
to facilitate the detection of both RNA gastroenteritis 
viruses such as rotaviruses, noroviruses, and 
astroviruses and DNA gastroenteritis viruses such as 
adenoviruses. Viral genomes were extracted from 
10% diluted stool samples and prepared for detection 
of viral gastroenterities by both RT-PCR and PCR 
using sets of oligonucleotide primers specific to each 
type of virus as follow: 
 
Rotaviruses 
cDNA synthesis and PCR amplification: Viral 
RNA was extracted from 200 µl aliquot of 10% stool 
sample, using Axygen® Kit (Axygen biosciences, Cat. 
No. AP-MN-BF-VNA-250), according to the instruc-
tions of the supplier. Reverse transcription (RT) was 
carried out using a mixture of 10 µl of extracted viral 
RNA, 5 µl random primer (25 pmol/µl), and 20 µl 
DEPC treated water. The reaction mixture, 35 µl, was 
heated at 65ºC for 5 min. and chilled on ice for 2 min. 
35 µl of the reaction mixture was added to 1µl of 200 
U/µl M-MLV Reverse Transcriptase (Promega, Cat. # 
M1701), 10 µl RT-buffer, 4 µl of 10mM each dNTPs 
(Promega, Cat. # U1511). The mixture was heated at 
42ºC for 60 min and 37ºC for 30 min, for cDNA 
synthesis, followed by 95ºC for 5 min. Nested RT-
PCR the reaction takes place in two rounds; of The 
first-round PCR was carried out in 50l reaction 
mixture containing 10 μl of the synthesized cDNA, 5 l 
10 x PCR Buffer, 4 l of 25 mM MgCl2 (Promega, Cat. 
# A3511), 0.5 l of 5 U/l Go Taq DNA Polymerase 
(Promega, Cat. # M8305), 1 l (50 pmol/l) of sense 
primer, 1 l (50 pmol/l) of antisense primer, 4 l of 10 
mM each dNTPs (Promega, Cat. # U1511) and 24.5 
l DEPC treated water. For PCR amplification of G 
type rotaviruses (Table 1), an initial denaturation of 
5min at 95ºC was applied and 35 cycles for first round 
and 30 cycles for 2nd round were used. The PCR 
profile for first round was 94ºC for 1 min, 52ºC for 1 
min, and 72ºC for 1 min, and an additional extension 
at 72ºC for 7min was applied using a PCR machine 
(BioMetra, UK). The amplified RT-PCR products were 
electrophoresed through 1.5% agarose gels in Tris 
acetate/EDTA buffer against 100 bp DNA ladder 
(Promega, Cat. # G2101) and visualized by staining 
with ethidium bromide. Bands were visualized under 
UV light using UV transilluminator. The obtained band 
size is determined with the reference of the DNA 
ladder. 
Table 1: PCR reaction profile for G type Rotaviruses. 
Step 
Reaction 
1st round 2nd round 
Temp (°C) Time (min) Temp (°C) Time (min) 
Denaturation 94 1 min 94 1 min 
Annealing 52 1 min 42 2 min 
Extension 72 1 min 72 1 min 
No. of cycles 35 30 
Expected Product 881 bp 175-754 bp 
 
For the second round; PCR amplification was 
carried out from the first round PCR reaction in 50l 
reaction mixture containing 2 l of 1st round PCR 
product, 5 l 10 x PCR Buffer, 4 l of 25 mM MgCl2 
(Promega, Cat. # A3511), 0.5 l of 5 U/l Go Taq 
Flexi DNA Polymerase (Promega Cat. No. M8301), 1 
l downstream primer (50 pmol/l), 1 l of 8 cocktail 
upstream primers (50 pmol/l each), 4 l of 10 mM 
each dNTPs (Promega, Cat. # U1511) and 25.5 l 
DEPC treated water. The PCR profile for the second 
round was an initial denaturation of 5 min at 95ºC 
followed by 30 cycle at 94ºC for 1 min, 42ºC for 2 min, 
and 72ºC for 1 min, and an additional extension at 
72ºC for 7 min was applied using a PCR machine 
(BioMetra, UK). The amplified RT-PCR products were 
electrophoresed through 1.5% agarose gels in Tris 
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acetate/EDTA buffer against 100bp DNA ladder 
(Promega, Cat. # G2101) and visualized by staining 
with ethidium bromide. Bands were visualized under 
UV light using UV transilluminator. The obtained band 
size is determined with the reference of the DNA 
ladder.  
For PCR amplification of P type rotaviruses 
(Table 2), an initial denaturation of 5min at 95ºC and 
35 cycles for first round and 30 cycles for 2nd round. 
For 1st round PCR cycles profiles was at 94ºC for 
1min, 50ºC for 2 min, and 72ºC for 1 min, and an 
additional extension at 72ºC for 7 min. Profile was 
applied using a PCR machine (BioMetra, UK). The 
amplified RT-PCR products were electrophoresed 
through 1.5% agarose gels in Tris acetate/EDTA 
buffer against 100bp DNA ladder (Promega, Cat. # 
G2101) and visualized by staining with ethidium 
bromide. Bands were visualized under UV light using 
UV transilluminator. The obtained band size is 
determined with the reference of the DNA ladder. 
Table 2: PCR reaction profile for P type Rotaviruses. 
Step 
Reaction 
1st round 2nd round 
Temp (°C) Time (min) Temp (°C) Time (min) 
Denaturation 94 1 min 94 1 min 
Annealing 50 2 min 45 2 min 
Extension 72 1 min 72 1 min 
No. of cycles 35 30 
Expected Product 876 bp 276-583 bp 
 
For the second round; PCR amplification was 
carried out from the first round PCR reaction in 50 l 
reaction mixture containing 2 l of 1st round PCR 
product, 5l 10x PCR Buffer, 4 l of 25 mM MgCl2 
(Promega, Cat. # A3511), 0.5 l of 5 U/l Go Taq 
Flexi DNA Polymerase (Promega Cat. No. M8301), 1 
l of a 7 cocktail downstream primers (50 pmol/l 
each), 1 l upstream primer (50 pmol/l), 4 l of 10 
mM each dNTPs (Promega, Cat. # U1511) and 26.5 
l DEPC treated water. The PCR profile for the 
second round was an initial denaturation of 5min at 
95ºC followed by 30 cycle at 94ºC for 1 min, 45ºC for 
2 min, and 72ºC for 1 min, and an additional extension 
at 72ºC for 7 min was applied using a PCR machine 
(BioMetra, UK). The amplified RT-PCR products were 
electrophoresed through 1.5% agarose gels in Tris 
acetate/EDTA buffer against 100bp DNA ladder 
(Promega, Cat. # G2101) and visualized by staining 
with ethidium bromide. Bands were visualized under 
UV light using UV transilluminator. The obtained band 
size is determined with the reference of the DNA 
ladder. 
 
Astroviruses 
cDNA synthesis and PCR amplification: Viral 
RNA was extracted from 200 µl aliquot of 10% stool 
sample, using Axygen® Kit (Axygen biosciences, Cat. 
No. AP-MN-BF-VNA-250), according to the 
instructions of the manufacturer. Reverse transcription 
(RT) was carried out using a mixture of 10 µl of 
extracted viral RNA, 5 µl random primer (25 pmol/µl), 
and 20 µl DEPC treated water. The reaction mixture, 
35 µl, was heated at 65ºC for 5 min and chilled on ice 
for 2 min 35 µl of the reaction mixture was added to 1 
µl of 200 U/µl M-MLV Reverse Transcriptase 
(Promega, Cat. # M1701), 10 µl RT-buffer, 4 µl of 10 
mM each dNTPs (Promega, Cat. # U1511). The 
mixture was heated at 42ºC for 60 min and 37ºC for 
30 min, for cDNA synthesis, followed by 95ºC for 5 
min. The RT-PCR reaction was carried out in 50 l 
reaction mixture containing 10 μl of the synthesized 
cDNA, 5 l 10 x PCR Buffer, 4 l of 25 mM MgCl2 
(Promega, Cat. # A3511), 0.5 l of 5 U/l Go Taq 
DNA Polymerase (Promega, Cat. # M8305), 1 l (50 
pmol/l) of sense primer,  1l (50 pmol/l) of 
antisense primer, 4 l of 10 mM each dNTPs 
(Promega, Cat. # U1511) and 24.5 l DEPC treated 
water. For PCR amplification for astroviruses (Table 
3), was start by an initial denaturation of 5min at 95ºC, 
followed by 40 thermal cycles. The PCR profile for 
thermal cycles was 94ºC for 1 min, 50ºC for 1 min, 
and 72ºC for 1 min, and an additional extension at 
72ºC for 7 min was applied using a PCR machine 
(BioMetra, UK). The amplified RT-PCR products were 
electrophoresed through 1.5% agarose gels in Tris 
acetate/EDTA buffer against 100 bp DNA ladder 
(Promega, Cat. # G2101) and visualized by staining 
with ethidium bromide. Bands were visualized under 
UV light using UV transilluminator. The obtained band 
size is determined with the reference of the DNA 
ladder. 
Table 3: PCR reaction profile for Astroviruses. 
 
Step 
Reaction 
Temp (°C) Time (min) 
Denaturation 94 1 min 
Annealing 50 2 min 
Extension 72 1 min 
No. of cycles 40 
Expected Product 449 bp 
 
Noroviruses genogroup I (GI) 
cDNA synthesis and PCR amplification: Viral 
RNA was extracted from 200 µl aliquot of 10% stool 
sample, using Axygen® Kit (Axygen biosciences, Cat. 
No. AP-MN-BF-VNA-250), according to the 
instructions of the manufacturer. Reverse transcription 
(RT) was carried out using a mixture of 10 µl of 
extracted viral RNA, 5 µl random primer (25 pmol/µl), 
and 20 µl DEPC treated water. The reaction mixture, 
35 µl, was heated at 65ºC for 5 min. and chilled on ice 
for 2 min. 35 µl of the reaction mixture was added to 1 
µl of 200 U/µl M-MLV Reverse Transcriptase 
(Promega, Cat. # M1701), 10 µl RT-buffer, 4 µl of 
10mM each dNTPs (Promega, Cat. # U1511). The 
mixture was heated at 42ºC for 60 min and 37ºC for 
30 min, for cDNA synthesis, followed by 95ºC for 5 
min. The RT-PCR reaction was carried out in 50 l 
reaction mixture containing 10 μl of the synthesized 
cDNA, 5 l 10 x PCR Buffer, 4 l of 25 mM MgCl2 
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(Promega, Cat. # A3511), 0.5l of 5U/l Go Taq DNA 
Polymerase (Promega, Cat. # M8305), 1 l (50 
pmol/l) of sense primer, 1 l (50 pmol/l) of 
antisense primer, 4 l of 10mM each dNTPs 
(Promega, Cat. # U1511) and 24.5 l DEPC treated 
water. For PCR amplification for Noroviruses GI 
(Table 4), the reaction started by an initial 
denaturation of 5 min at 95ºC, followed by 40 thermal 
cycles. The PCR profile for thermal cycles was 94ºC 
for 45 sec, 50ºC for 45 sec, and 72ºC for 1 min, and 
an additional extension at 72ºC for 7 min was applied 
using a PCR machine (BioMetra, UK). The amplified 
RT-PCR products were electrophoresed through 1.5% 
agarose gels in Tris acetate/EDTA buffer against 100 
bp DNA ladder (Promega, Cat. # G2101) and 
visualized by staining with ethidium bromide. Bands 
were visualized under UV light using UV 
transilluminator. The obtained band size is determined 
with the reference of the DNA ladder. 
Table 4: PCR reaction profile for Noroviruses GI. 
 
Step 
Reaction 
Temp (°C) Time (min) 
Denaturation 94 45 sec 
Annealing 50 45 sec 
Extension 72 1 min 
No. of cycles 40 
Expected Product 329 bp 
 
 
Noroviruses genogroup II (GII) 
cDNA synthesis and PCR amplification: Viral 
RNA was extracted from 200 µl aliquot of 10% stool 
sample, using Axygen® Kit (Axygen biosciences, Cat. 
No. AP-MN-BF-VNA-250), according to the 
instructions of the manufacturer. Reverse transcription 
(RT) was carried out using a mixture of 10 µl of 
extracted viral RNA, 5 µl random primer (25 pmol/µl), 
and 20 µl DEPC treated water. The reaction mixture, 
35 µl, was heated at 65ºC for 5 min and chilled on ice 
for 2 min. 35µl of the reaction mixture was added to 
1µl of 200 U/µl M-MLV Reverse Transcriptase 
(Promega, Cat. # M1701), 10 µl RT-buffer, 4 µl of 
10mM each dNTPs (Promega, Cat. # U1511). The 
mixture was heated at 42ºC for 60 min and 37ºC for 
30 min, for cDNA synthesis, followed by 95ºC for 5 
min. The RT-PCR reaction was carried out in 50 l 
reaction mixture containing 10 μl of the synthesized 
cDNA, 5 l 10 x PCR Buffer, 4 l of 25 mM MgCl2 
(Promega, Cat. # A3511), 0.5 l of 5 U/l Go Taq 
DNA Polymerase (Promega, Cat. # M8305), 1 l (50 
pmol/l) of sense primer, 1 l (50 pmol/l) of 
antisense primer, 4 l of 10 mM each dNTPs 
(Promega, Cat. # U1511) and 24.5 l DEPC treated 
water. For PCR amplification for Noroviruses GII 
(Table 5), the reaction started by an initial 
denaturation of 5min at 95ºC, followed by 40 thermal 
cycles. The PCR profile for thermal cycles was 94ºC 
for 30 sec, 50ºC for 30 sec, and 72ºC for 1 min, and 
an additional extension at 72ºC for 7 min was applied 
using a PCR machine (BioMetra, UK). The amplified 
RT-PCR products were electrophoresed through 1.5% 
agarose gels in Tris acetate/EDTA buffer against 100 
bp DNA ladder (Promega, Cat. # G2101) and 
visualized by staining with ethidium bromide. Bands 
were visualized under UV light using UV 
transilluminator. The obtained band size is determined 
with the reference of the DNA ladder. 
Table 5: PCR reaction profile for Noroviruses GII. 
Step 
Reaction 
Temp (°C) Time (min) 
Denaturation 94 30 sec 
Annealing 50 30 sec 
Extension 72 1 min 
No. of cycles 40 
Expected Product 343 bp 
 
 
DNA Viruses (Adenoviruses) 
PCR amplification: Viral DNA was extracted 
from 200µl aliquot of 10% diluted stool samples, with 
sterile PBS pH 7.2, using Axygen® Kit, (Axygen 
biosciences, Cat. No. AP-MN-BF-VNA-250), 
according to the instructions of the manfacturer. 
Nested PCR was carried out where the reaction takes 
place in two rounds; of The first-round PCR was 
carried out in 50 l reaction mixture containing 10 μl of 
extracted DNA, 5 l 10 x PCR Buffer, 4 l of 25 mM 
MgCl2 (Promega, Cat. # A3511), 0.5 l of 5 U/l Go 
Taq DNA Polymerase (Promega, Cat. # M8305), 1 l 
(50 pmol/l) of sense primer (Adv-HEX1DEG-F10), 1 
l (50 pmol/l) of antisense primer (Adv-HEX2DEG-
R10), 4 l of 10 mM each dNTPs (Promega, Cat. # 
U1511) and 24.5 l DEPC treated water. For PCR 
amplification of adenoviruses (Table 6), an initial 
denaturation of 5 min at 95ºC was applied and 35 
cycles for first round and 35 cycles for 2nd round were 
used. The PCR profile for first round was 94ºC for 30 
sec, 55ºC for 30 sec, and 72ºC for 1 min, and an 
additional extension at 72ºC for 7 min was applied 
using a PCR machine (BioMetra, UK). The amplified 
PCR products were electrophoresed through 1.5% 
agarose gels in Tris acetate/EDTA buffer against 100 
bp DNA ladder (Promega, Cat. # G2101) and 
visualized by staining with ethidium bromide. Bands 
were visualized under UV light using UV 
transilluminator. The obtained band size is determined 
with the reference of the DNA ladder. 
For the second round; PCR amplification was 
carried out from the first round PCR reaction in 50 l 
reaction mixture containing 5 l of 1st round PCR 
product, 5 l 10 x PCR Buffer, 4 l of 25 mM MgCl2 
(Promega, Cat. # A3511), 0.5l of 5U/l Go Taq Flexi 
DNA Polymerase (Promega Cat. No. M8301), 1 l of 
(Adv-HEX3DEG-F10) downstream primer (50 
pmol/l), 1 l of (Adv-HEX4DEG-R10) upstream 
primers (50 pmol/l each), 4 l of 10 mM each dNTPs 
(Promega, Cat. # U1511) and 28.5 l DEPC treated 
water. The PCR profile for the second round was an 
initial denaturation of 5 min at 95ºC followed by 35 
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cycle at 94ºC for 30 sec, 55ºC for 30 sec, and 72ºC 
for 1 min, and an additional extension at 72ºC for 7 
min was applied using a PCR machine (BioMetra, 
UK). The amplified PCR products were 
electrophoresed through 1.5% agarose gels in Tris 
acetate/EDTA buffer against 100 bp DNA ladder 
(Promega, Cat. # G2101) and visualized by staining 
with ethidium bromide. Bands were visualized under 
UV light using UV transilluminator. The obtained band 
size is determined with the reference of the DNA 
ladder. 
Table 6: PCR reaction profile for Adenoviruses. 
Step 
Reaction 
1st round 2nd round 
Temp (°C) Time (min) Temp (°C) Time (min) 
Denaturation 94 30 sec 94 30 sec 
Annealing 55 30 sec 55 30 sec 
Extension 72 1 min 72 1 min 
No. of cycles 35 35 
Expected Product 301 bp 171 bp 
 
 
Oligonucleotide primers 
Universal viral gastroenteritis oligonucleotide 
primers sequences were obtained from Bioneer 
Company, as purified lyophilized primers. Universal 
primers for G typing rotaviruses was selected for 
amplification of segment 9 as previously described by 
Iturriza-Gomara, et al., [21]. These primer pairs are 
semi nested primers designed to amplify the highly 
conserved region among all known rotaviruses strains 
and specific for gene segment 9, as listed and shown 
in Table 7. Universal primers for P typing rotaviruses 
was selected for amplification of VP7 gene segment 
as described by Gentsch et al., [22] and also listed 
and shown in Table 7. For detection of astroviruses 
sets of primers were selected and used as described 
by Noel et al., [23] (Table 7), and noroviruses sets of 
primers were used as described by Kojima et al., [24] 
(Table 7). For adenoviruses PCR the primer sets 
listed in Table 7, described by Allard et al., [25] and 
designed to amplify the highly conserved region of 
hexon gene which is very similar in many types of 
adenoviruses. 
 
Analysis of PCR products 
 PCR products were analyzed by 
electrophoresis using 1.5% Agarose gel with Ethidium 
bromide, as follow: 1.5 g umltrapure Agarose powder 
(BDH), was dissolved in 100 ml Tris-Borate-EDTA 
(TBE) and cooked at microwave for 2 min. Agarose 
was cooled down to about 42-45C and 8 µl of 
Ethidium bromide (10 mg/ml) was added. The melted 
agarose was poured into horizontal electrophoresis 
chamber with 20 whole comb and left to dry at room 
temperature. 10 µl of PCR products were mixed with 2 
µl of loading buffer (1% sodium dodecyl sulphate, 
0.25% bromophenol blue and 0.1M EDTA, pH 8.0), 
and applied into agarose gel and electrophoresed at 
100V for 1-1.5 hr. Presumptive and confirmed product 
bands were visualized and compared with standard 
100 bp DNA marker (Promega, USA, Cat. # G2101). 
Bands were visualized under UV light using UV 
transilluminator and gel documentation system.  
Table 7: The list of primers sets used to detect viruses. 
Primer Sequence Polarity Location 
 
G genotype of rotaviruses 
1st  round 
Rota VP7-F10 ATGTATGGTATTGAATATTACCAC + 51 
Rota VP7-R10 AACTTGCCACCATTTTTTCC - 932 
2nd round 
Rota G1-aBT1-10 CAAGTACTCAAATCAATGATGG + 314 
Rota G2-acT2-10 CAATGATATTAACACATTTTCTGTG + 411 
Rota G- 10 ACGAACTCAACACGAGAGG + 250 
Rota G4-2aDT4-10 CGTTTCTGGTGAGGAGTTG + 480 
Rota G8-aAT8-10 GTCACACCATTTGTAAATTCG + 178 
Rota G9-10 CTTGATGGACTAYAAATAC + 757 
Rota G10-10 ATGTCAGACTACARATACTG + 666 
Rota G9-VP7aFT9d-10 CTTGATGTRACTAYAAMTAC + 757 
Rota VP7-R10 AACTTGCCACCATTTTTTCC - 932 
 
P genotype of rotaviruses 
1st  round: 
Con3-10 TGGCTTCGCCATTTTATAGA + 11 
Con2-10 ATTTCGGACCATTTATAACC - 885 
2nd round: 
Con3-10 TGGCTTCGCCATTTTATAGA + 11 
Rota P(8)-1T1-10 TCTACTTGGATAACGTGC - 356 
Rota P(4)-2T1-10 CTATTGTTAGAGGTTAGAGTC - 494 
Rota P(6)-3T1-10 TGTTGATTAGTTGGATTCAA - 278 
Rota P(9)-4T1-10 TGAGACATGCAATTGGAC - 402 
Rota P(10)-5T1-10 ATCATAGTTAGTAGTCGG - 594 
Rota P(11) -10 GTAAACATCCAGAATGTG - 323 
Rota P(8)-1T-1D-10 TCTACTGGRTTRACNTGC - 356 
 
Astroviruses 
Astro-mon-269-F-10 CAACTCAGGAAACAGGGTGT + 4526 
Astro-mon-270-R-10 TTAGTGAGCCACCAGCCATC - 4974 
 
Noroviruses Genogroup I (GI) 
Noro GISKF-10 CTGCCCGAATTYGTAAATGA + 5342 
Noro GISKR-10 CCAACCCARCCATTRTACA - 5671 
 
Noroviruses Genogroup II (GII) 
Noro GII SKF-10 CNTGGGAGGGCGATCGCAA + 5058 
Noro GII SKF-10 CCRCCNGCATRHCCRTTRTACAT - 5401 
 
Adenoviruses 
1
st
  round 
Adv-HEX1 DEG10 GCCSCARTGGKCWTACATGCACATC + 21 
Adv-HEX 2 DEG10 CAGCACSCCICGRATGTCAAA - 321 
2
nd
 round 
Adv-HEX3 DEG- F10 GCCCGYGCMACIGAIACSTACTTC + 68 
Adv-HEX4 DEG-R1 CCYACRGCCAGIGTRWAICGMRCYTTGTA - 239 
 
Statistical analysis 
Statistical analysis was performed using the 
SPSS statistical package software for windows 
version 21 (SSPS Inc, Pennsylvania, and USA). 
Parametric variables are expressed as the mean ± 
SD. Differences between parametric variables among 
the obese and overweight versus control groups were 
evaluated using 2-tailed unpaired t-test. Pearson’s 
correlation coefficients were used to evaluate 
correlations between the data exhibiting parametric 
distribution. P value <0.05 was considered significant 
difference and p < 0.005 was considered highly 
significant difference.  
 
Results 
 
Serum levels of I-FABP were higher in GE 
cases group compared to control group (1026.4 pg/ml 
vs 267.9 pg/ml, respectively). Table 8 showed serum 
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I-FABP level in gastroenteritis cases group versus 
control group. Serum levels of I-FABP were higher in 
the 46 Rotavirus - GE cases compared to the 9 
adenovirus – GE cases. Also these levels were higher 
in the 46 Rotavirus- GE cases compared to the 4 
Astrovirus-GE cases. There were 3 cases with mixed 
Rotavirus and Adenovirus co-infections whose serum 
I-FABP levels shouted to 1425 pg/ml. Similarly, the 
other 3 cases of mixed Rotavirus and Astrovirus co-
infections had those levels reaching 1217 pg/ml. 
Although those cases were few in number but their 
importance will be stated in the discussion.  
Table 8: Serum I-FABP level in gastroenteritis cases group 
versus control group. 
Serum I-FABP conc. 
(pg/ml) 
Number Mean ± SD P- value 
GE cases 93 1026.4 ± 494.4 P<0.001 
Control 28   267.9 ± 200.4 P<0.001 
 
**highly significant difference at p<0.001. 
 
Table 9 showed the serum I-FABP level 
according to type of virus. 
Table 9: Serum I-FABP level according to type of virus. 
Variable 
Rotavirus 
cases 
Adenovirus 
cases 
Astrovirus 
cases 
Rotavirus 
and 
Adenovirus  
cases 
Rotavirus 
and 
Astrovirus  
cases 
Total GE cases Control 
No. of cases 46 9 4 3 3 93 28 
Serum  
I-FABP 
1017.4 ± 456* 653 ± 419 408 ± 210 1425 ± 871 1217 ± 453 1217 ± 453    267.9 ± 200.4* 
     *Significant difference at p<0.05. 
 
Paired Samples Test revealed statistically 
significant difference in I-FABP level when mild and 
severe degrees of dehydration were compared. On 
the other hand, statistically insignificant difference in I-
FABP level between mild and moderate degrees of 
dehydration is observed in Table 10. 
Table 10: Comparisons between serum I-FABP levels 
according to degree of dehydration in the studied groups. 
Serum I-FABP level t P value 
Mild vs  Moderate cases 0.318 0.760 
Mild vs  Severe cases 2.564 0.037* 
*Significant difference at p<0.05. 
 
Significant positive correlations were found 
between hospitalization and serum level of I-FABP as 
well as dehydration (P=0.000). Furthermore, a 
significant positive correlation was found out between 
hospitalization and the degree of fever (P=0.002) as 
shown in Table 11. 
Table 11: Correlations between hospitalization and other 
parameters in the study group. 
Hospitalization 
 
Serum 
I-FABP 
Dehydration 
severity 
Fever 
Pearson correlation 0.223* 0.713** 0.322** 
Sig. (2-tailed) 0.045 0.000 0.002 
*Significant difference at p<0.05, **highly significant difference at p<0.001. 
 
 
Discussion 
 
Loss of gut wall integrity is consequence of 
low flow states associated with viral gastroenteritis. It 
is involved in the development of various inflammatory 
syndromes, including sepsis, and multiple organ 
failure. The delay in diagnosis is a major factor 
associated with the high morbidity and mortality of 
patients with intestinal ischemia [26]. Although 
diagnostic accuracy of intestinal ischemia has 
improved with the development of computed 
tomography (CT) [27] a laboratory test for clinical use 
is necessary [28]. Intestinal fatty acid–binding protein 
(I-FABP) is a useful marker in the detection of 
intestinal ischemia. These are mainly expressed in the 
intestinal villi which are the initial site of destruction in 
acute intestinal inflammation, injury, and ischemia all 
of which are present in viral gastroenteritis 
pathophysiology [29]. It has emerged as a valuable 
marker in the diagnosis of intestinal damage at an 
early stage [30, 31]. The current study provides 
additional information concerning the clinical utility of 
serum I-FABP levels during intestinal ischemia 
reperfusion. 
Our present study dealt with the promising 
issue of resorting to serum I-FABPs in the early 
prediction of intestinal injury in viral GE particularly 
Rota viral GE. This is very crucial to Egypt and other 
developing countries because Rota virus vaccination 
is still fighting against poor sanitation in general and 
the sewage polluted River-Nile water in particular. Our 
study worked upon proving that, I-FABP could be 
made use as early predictor of the gut injury in viral 
GE. 
Several studies showed that plasma I-FABP 
levels were significantly increased in patients 
suspected with intestinal ischemia, as compared with 
patients with other diagnoses [32]. It increases within 
the early stages of intestinal ischemia [33]. In our 
present study, serum I-FABP levels were significantly 
higher in GE cases compared to control group. 
Many recent studies have also reported the 
existence of coinfections by different viruses whether 
in Egypt or in other countries [34-36]. Some studies 
have confirmed that in RV-GE cases, viral co-
infections (and even bacterial and parasitic) 
aggravated the clinical picture of the disease and 
caused an extension of the hospital stay period [37, 
38]. Some recent studies reported the predominance 
of Adenovirus and Astrovirus GE in certain countries 
in particular months of the year [39-40]. In our present 
study, we did have serious conditions which 
necessitated hospitalization, and serum I-FABPs 
levels were also higher in RV-GE cases compared to 
Adeno and Astro viruses GE cases. In addition, their 
levels were also higher in GE cases infected with 
mixed viruses (coinfections). Similar to our results, 
Ishimura et al., [41], and Pelsers et al., [42] found an 
elevation in serum levels of I-FABP in cases of 
intestinal inflammation, injury and ischemia. In 
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addition, their levels were not detectable in serum of 
healthy subjects. 
Guthmann et al., [17] ensured that, I-FABP 
was a very specific marker for detection of intestinal 
injury which led to severe stage III. In accordance with 
our results, some studies emphasized that individuals 
who suffered from necrotizing enterocolitis (NEC), and 
acute ischemic diseases had their serum I-FABP 
concentrations applicable for detection of intestinal 
injury [20]. Again, in agreement with our study, Panl et 
al., [43] assumed that I-FABP might constitute a 
useful marker for acute intestinal failure in critically ill 
patients. 
Machado et al., [36] found out that levels of I-
FABP were early marker of intestinal necrosis after 
acute pancreatitis and after liver surgery and aortic 
surgery. In this study, critically ill patients had an 
evaluation of their intestinal failure via evaluating the 
circulating I-FABP values. Many studies also 
described I-FABP as plasma markers for intestinal 
injury [42, 43]. Although they are relatively old ones, 
still very important because all those research studies 
agreed upon that finding and the rarity of similar 
recent studies does not be little the crucial importance 
of old ones. 
In our study, we observed a significant 
elevation in serum I-FABP level on comparing 
severely dehydrated groups with mild dehydrated 
cases. There was a positive correlation between the 
serum level of I-FABP and hospitalized patients, 
taking into consideration that severely dehydrated 
children needed hospitalization. 
In conclusions, this study provides new insight 
into the significance of serum I-FABP following human 
intestinal injury. The results demonstrate that the 
extent of intestinal tissue damage is related to the 
duration of injury. In addition, systemic I-FABP levels 
can very well differentiate between mild, reversible 
damage and more extensive irreversible intestinal 
damage. Future studies should be conducted using I-
FABP in the decision-making during the diagnostic 
workup of patients suspected for intestinal injury, to 
integrate I-FABP in daily clinical practice. 
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